149 related articles for article (PubMed ID: 15710572)
41. IFR4/MUM1-positive lymphoma in Waldeyer ring with co-expression of CD5 and CD10.
Chen L; Al-Kzayer LF; Liu T; Kobayashi N; Nakazawa Y; Koike K
Pediatr Blood Cancer; 2017 Feb; 64(2):311-314. PubMed ID: 27616053
[TBL] [Abstract][Full Text] [Related]
42. Nuclear protein dysregulation in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia.
Roberts MJ; Chadburn A; Ma S; Hyjek E; Peterson LC
Am J Clin Pathol; 2013 Feb; 139(2):210-9. PubMed ID: 23355206
[TBL] [Abstract][Full Text] [Related]
43. Immunohistochemical and other prognostic factors in B cell non Hodgkin lymphoma patients, Kampala, Uganda.
Tumwine LK; Agostinelli C; Campidelli C; Othieno E; Wabinga H; Righi S; Falini B; Piccaluga PP; Byarugaba W; Pileri SA
BMC Clin Pathol; 2009 Dec; 9():11. PubMed ID: 20003543
[TBL] [Abstract][Full Text] [Related]
44. Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials.
Bernd HW; Ziepert M; Thorns C; Klapper W; Wacker HH; Hummel M; Stein H; Hansmann ML; Ott G; Rosenwald A; Müller-Hermelink HK; Barth TF; Möller P; Cogliatti SB; Pfreundschuh M; Schmitz N; Trümper L; Höller S; Löffler M; Feller AC;
Haematologica; 2009 Nov; 94(11):1569-80. PubMed ID: 19880780
[TBL] [Abstract][Full Text] [Related]
45. MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity.
Schmidt J; Federmann B; Schindler N; Steinhilber J; Bonzheim I; Fend F; Quintanilla-Martinez L
Br J Haematol; 2015 Jun; 169(6):795-803. PubMed ID: 25819228
[TBL] [Abstract][Full Text] [Related]
46. MIST1-a novel marker of plasmacytic differentiation.
Yeung CC; Mills JC; Hassan A; Kreisel FH; Nguyen TT; Frater JL
Appl Immunohistochem Mol Morphol; 2012 Dec; 20(6):561-5. PubMed ID: 22495370
[TBL] [Abstract][Full Text] [Related]
47. Marginal zone B-cell lymphoma of the pulmonary mucosa-associated lymphoid tissue: A case report.
Li H; Wang T; Wei X; Dang X
Oncol Lett; 2015 Sep; 10(3):1731-1734. PubMed ID: 26622741
[TBL] [Abstract][Full Text] [Related]
48. Diagnostic Algorithm of Common Mature B-Cell Lymphomas by Immunohistochemistry.
Wang HY; Zu Y
Arch Pathol Lab Med; 2017 Sep; 141(9):1236-1246. PubMed ID: 28608720
[TBL] [Abstract][Full Text] [Related]
49. Expression and prognostic evaluation of oxidative stress markers in an immunohistochemical study of B-cell derived lymphomas.
Pasanen AK; Kuitunen H; Haapasaari KM; Karihtala P; Kyllönen H; Soini Y; Turpeenniemi-Hujanen T; Kuittinen O
Leuk Lymphoma; 2012 Apr; 53(4):624-31. PubMed ID: 21929285
[TBL] [Abstract][Full Text] [Related]
50. CD10-positive mantle cell lymphoma: clinicopathologic and prognostic study of 30 cases.
Xu J; Medeiros LJ; Saksena A; Wang M; Zhou J; Li J; Yin CC; Tang G; Wang L; Lin P; Li S
Oncotarget; 2018 Feb; 9(14):11441-11450. PubMed ID: 29545910
[TBL] [Abstract][Full Text] [Related]
51. Management of marginal zone lymphomas.
Thieblemont C; Coiffier B
Curr Treat Options Oncol; 2006 May; 7(3):213-22. PubMed ID: 16615877
[TBL] [Abstract][Full Text] [Related]
52. Primary cutaneous marginal zone B-cell lymphoma: a report of 9 cases.
de la Fouchardière A; Balme B; Chouvet B; Sebban C; Perrot H; Claudy A; Bryon PA; Coiffier B; Berger F
J Am Acad Dermatol; 1999 Aug; 41(2 Pt 1):181-8. PubMed ID: 10426886
[TBL] [Abstract][Full Text] [Related]
53. Flow cytometric expression of CD71, CD81, CD44 and CD39 in B cell lymphoma.
Espasa A; Tapia G; Vergara S; Raya M; Juncà J; Sorigue M
Scand J Clin Lab Invest; 2021 Sep; 81(5):413-417. PubMed ID: 34057378
[TBL] [Abstract][Full Text] [Related]
54. Misdiagnosis of primary hepatic marginal zone B cell lymphoma of mucosa-associated lymphoid tissue type, a case report.
Li LX; Zhou ST; Ji X; Ren H; Sun YL; Zhang JB; Wang HB; Liu ZW
World J Surg Oncol; 2016 Mar; 14():69. PubMed ID: 26956381
[TBL] [Abstract][Full Text] [Related]
55. Expression of activation markers CD23 and CD69 in B-cell non-Hodgkin's lymphoma.
Erlanson M; Grönlund E; Löfvenberg E; Roos G; Lindh J
Eur J Haematol; 1998 Feb; 60(2):125-32. PubMed ID: 9508354
[TBL] [Abstract][Full Text] [Related]
56. Transformations of marginal zone lymphomas and lymphoplasmacytic lymphomas: Report from the 2021 SH/EAHP Workshop.
Cook JR; Amador C; Czader M; Duffield A; Goodlad J; Ott G; Xiao W; Dave S; Thakkar D; Thacker E; Dogan A; Wasik M; Nejati R
Am J Clin Pathol; 2023 Apr; ():. PubMed ID: 37186259
[TBL] [Abstract][Full Text] [Related]
57. Proliferation activity in canine lymphomas.
Sokołowska J; Micun J; Malicka E; Lechowski R
Pol J Vet Sci; 2012; 15(4):727-34. PubMed ID: 23390763
[TBL] [Abstract][Full Text] [Related]
58. Rare mature B-cell lymphomas in children and adolescents.
Woessmann W; Quintanilla-Martinez L
Hematol Oncol; 2019 Jun; 37 Suppl 1():53-61. PubMed ID: 31187530
[TBL] [Abstract][Full Text] [Related]
59. CD5-Positive Primary Cutaneous Diffuse Large B-Cell Lymphoma-Leg Type.
Papoudou-Bai A; Marinos L; Vassou A; Kapsali E; Kanavaros P
Case Rep Dermatol Med; 2019; 2019():3730915. PubMed ID: 30792929
[TBL] [Abstract][Full Text] [Related]
60. CD180 expression in B-cell lymphomas: A multicenter GEIL study.
Mayeur-Rousse C; Guy J; Miguet L; Bouyer S; Geneviève F; Robillard N; Solly F; Maar A; Bené MC; Mauvieux L;
Cytometry B Clin Cytom; 2016 Sep; 90(5):462-6. PubMed ID: 26384474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
